Loading...
Chemical structure of AU-15330

GC64271

AU-15330

Also known as (2S,4R)-1-[(2S)-2-[[2-[4-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]piperazin-1-yl]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide

AU-15330 is a proteolysis-targeting chimera (PROTAC) degrader of the SWI/SNF ATPase subunits, SMARCA2 and SMARCA4· AU-15330 induces potent inhibition of tumour growth in xenograft models of prostate cancer and synergizes with the AR antagonist enzalutamide· AU-15330 induces disease remission in castration-resistant prostate cancer (CRPC) models without toxicity

ChemicalCAS2380274-50-8MW755.93FormulaC39H49N9O5S
CAS number
2380274-50-8
Molecular weight
755.93
Formula
C39H49N9O5S
Solubility
DMSO ： 140 mg/mL (185·20 mM; Need ultrasonic)
InChIKey
HDCCMCFIGHIDJR-TUDDPRDOSA-N
Catalogue number
GC64271
Brand
GLPBIO
Computed properties PubChem CID 156168451 · XLogP 3.3 · TPSA 218 Ų · H-bond donors 5
XLogP
3.3
TPSA
218 Ų
H-bond donors
5
H-bond acceptors
12
Rotatable bonds
11
Heavy atoms
54

SMILES CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CN4CCN(CC4)C5=CC(=NN=C5N)C6=CC=CC=C6O)O

Computed descriptors from PubChem (CID 156168451), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.